tradingkey.logo

Picard Medical Inc

PMI
查看詳細走勢圖
1.880USD
+0.180+10.65%
收盤 02/06, 16:00美東報價延遲15分鐘
138.56M總市值
虧損本益比TTM

Picard Medical Inc

1.880
+0.180+10.65%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+10.65%

5天

+7.43%

1月

-1.57%

6月

0.00%

今年開始到現在

+7.43%

1年

0.00%

查看詳細走勢圖

TradingKey Picard Medical Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Picard Medical Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力較大。當前估值合理,在醫療設備與耗材行業排名154/205位。機構持股佔比非常低,中期看,股價處於下降通道。近一個月,市場表現較強,基本面評分較高,但較強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Picard Medical Inc評分

相關信息

行業排名
154 / 205
全市場排名
546 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Picard Medical Inc亮點

亮點風險
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
業績增長期
公司處於發展階段,最新年度總收入4.39M美元
估值低估
公司最新PE估值-4.28,處於3年歷史低位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉28.14K股

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Picard Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Picard Medical Inc簡介

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
公司代碼PMI
公司Picard Medical Inc
CEOSchnegelsberg (Patrick N.J)
網址
KeyAI